4/2
08:11 am
mnpr
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its "hold" rating re-affirmed by analysts at Jones Trading.
High
Report
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its "hold" rating re-affirmed by analysts at Jones Trading.
4/1
08:00 am
mnpr
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Medium
Report
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
3/31
08:12 am
mnpr
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments [Yahoo! Finance]
Low
Report
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments [Yahoo! Finance]
3/31
08:00 am
mnpr
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
Medium
Report
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
3/19
08:04 am
mnpr
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $76.00 price target on the stock.
High
Report
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $76.00 price target on the stock.
1/23
01:10 pm
mnpr
Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
Medium
Report
Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
1/22
08:14 am
mnpr
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its price target raised by analysts at HC Wainwright from $22.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Monopar Therapeutics Inc. (NASDAQ: MNPR) had its price target raised by analysts at HC Wainwright from $22.00 to $40.00. They now have a "buy" rating on the stock.
1/15
05:08 pm
mnpr
Monopar Therapeutics files to sell 882,761 shares of common stock for holders [Seeking Alpha]
High
Report
Monopar Therapeutics files to sell 882,761 shares of common stock for holders [Seeking Alpha]
1/10
08:03 am
mnpr
Monopar Therapeutics Inc. (NASDAQ: MNPR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $72.00 price target on the stock.
Low
Report
Monopar Therapeutics Inc. (NASDAQ: MNPR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $72.00 price target on the stock.